Research
BTIG Initiates Kazia Therapeutics at Buy With $34 Price Target
Kazia Therapeutics (KZIA) has an average rating of buy and mean price target of $27.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$KZIA
